You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study

Article metrics

Article menu

Download PDFPDF

XML
Original research
Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019898316
Jan 202010910943
Feb 202010010010
Mar 2020373713
Apr 2020303010
May 202030304
Jun 202020201
Jul 2020282812
Aug 2020303012
Sep 202031257
Oct 202027273
Nov 202034336
Dec 202027274
Jan 2021383412
Feb 202115141
Mar 202118183
Apr 202118173
May 202113136
Jun 202132326
Jul 202127287
Aug 202122226
Sep 2021272811
Oct 2021212118
Nov 2021201923
Dec 202130294
Jan 202226254
Feb 202223225
Mar 202236359
Apr 202234325
May 202237378
Jun 202235388
Jul 202219182
Aug 202238362
Sep 2022323411
Oct 202236359
Nov 202231286
Dec 202218174
Jan 202315142
Feb 2023454815
Mar 202319193
Apr 202313133
May 202323246
Jun 202318184
Jul 202322216
Aug 202314133
Sep 20231091
Oct 202316174
Nov 202324233
Dec 202327287
Jan 202412124
Feb 202448487
Mar 2024282810
Total15721546392